ISRCTN16425597进行中（未招募）3 期
A Phase III, multi-centre, randomized placebo-controlled trial of oral iron supplementation for the prevention of maternal anaemia
HS Blood and Transplant0 个研究点目标入组 11,020 人开始时间: 2023年11月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 11,020
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Healthy non-anaemic pregnant women of all parities (haemoglobin concentration [Hb] =110 g/l measured by the first-trimester blood profile) at booking or screening
- •2. A live fetus on a first-trimester ultrasound scan carried out for viability or dating.
- •3. 15 weeks + 6 days gestation or less
- •4. Aged 18 years and above
- •5. Able to give informed consent and willing to fulfil trial requirements
排除标准
- •1. Known haemoglobinopathies (women with haemoglobinopathy trait are still eligible)
- •2. Anaemia of any type, defined by British Society for Haematology guidelines
- •3. Severe gastrointestinal disease requiring ongoing treatment and potentially affecting tolerability of oral iron
- •4. Allergies to iron
- •5. Multiple pregnancies, given the higher iron demands
- •6. Known haemochromatosis
- •7. Recent red cell transfusion, within 30 days
研究者
相似试验
进行中（未招募）
1 期
A Study of Atezolizumab as Monotherapy And in Combination With Platinum-Based Chemotherapy compared to Platinum-Based Chemotherapy in Patients With Untreated Urothelial CarcinomaEUCTR2016-000250-35-EEF. Hoffmann-La Roche Ltd1,213
进行中（未招募）
1 期
A Study of Atezolizumab as Monotherapy And in Combination With Platinum-Based Chemotherapy compared to Platinum-Based Chemoteraphy in Patients With Untreated Urothelial CarcinomaEUCTR2016-000250-35-SIF. Hoffmann-La Roche Ltd1,213
进行中（未招募）
1 期
A Study of Atezolizumab as Monotherapy And in Combination With Platinum-Based Chemotherapy compared to Platinum-Based Chemotherapy in Patients With Untreated Urothelial Carcinomarothelial Carcinoma, locally advanced or metastaticMedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864EUCTR2016-000250-35-BEF. Hoffmann-La Roche Ltd1,213
进行中（未招募）
1 期
A Study of Atezolizumab as Monotherapy And in Combination With Platinum-Based Chemotherapy compared to Platinum-Based Chemotherapy in Patients With Untreated Urothelial Carcinomarothelial Carcinoma, locally advanced or metastaticMedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864EUCTR2016-000250-35-PLF. Hoffmann-La Roche Ltd1,213
进行中（未招募）
1 期
A Study of Atezolizumab as Monotherapy And in Combination With Platinum-Based Chemotherapy compared to Platinum-Based Chemotherapy in Patients With Untreated Urothelial CarcinomaEUCTR2016-000250-35-NLF. Hoffmann-La Roche Ltd1,213